Cargando…
COL1A1::PDGFB fusion-associated uterine sarcoma and response to Imatinib: A case report
Uterine sarcomas are rare neoplasms of the uterus, some of which are associated with distinctive gene fusions. COL1A1::PDGFB fusion uterine sarcoma is a recently described entity that shares the same genetic alteration as dermatofibrosarcoma protuberans. These uterine sarcomas have a nonspecific spi...
Autores principales: | Chapagain, Udita, Krigman, Hannah R., Hagemann, Ian S., Weiss, Mia C., Sun, Lulu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498399/ https://www.ncbi.nlm.nih.gov/pubmed/37711974 http://dx.doi.org/10.1016/j.gore.2023.101270 |
Ejemplares similares
-
COL1A1-PDGFB fusion uterine sarcoma and its response to Imatinib therapy
por: Grindstaff, Samuel L., et al.
Publicado: (2020) -
Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma
por: Lu, Linghui, et al.
Publicado: (2023) -
COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
por: Grindstaff, Samuel L., et al.
Publicado: (2019) -
Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to
COL1A1‐PDGFB
fusion gene
por: Hirose, Takeshi, et al.
Publicado: (2023) -
Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement
por: Makino, Maki, et al.
Publicado: (2016)